Forecasting Global Supply Chain
Forecasting Considerations for Global Supply Chain | [site:name] As identified by Dr. Roberto Torres (1) in a recent article, a high level of potential drugs fail to reach the market during clinical trials – which can incur large financial losses. Alongside a lack of efficacy, safety or economics, both poor clinical trial planning and a failure to assess the market for drug forecasting purposes are marked as key potential drivers for pre-approval drug development failure.The supply required for these trials represents one of the biggest challenges to be navigated. The efficient management of clinical supply demands precise planning, forecasting and internal coordination. Conflicting time zones can often hinder fluid communication levels in an international clinical trial.
Please note: That all fields marked with an asterisk (*) are required.